| 摘要 |
The 1,8-annelated quinoline derivatives, pharmaceutically acceptable acid addition salts or stereochemically isomeric forms thereof have the formula I wherein: the dotted line is an optional double bond; X is O or S; A is -CH=CH-, -CH2-CH2-, -CH2-CH2-CH2-, -CH2-O-, -CH2-CH2-O-, -CH2-S-, -CH2-CH2-S-, -CH=N-, -N=N- or -CO-NH- wherein optionally one hydrogen may be replaced by alkyl or Ar1; R1 and R2 are independently H, OH, halo, CN, alkyl, trihalomethyl, trihalomethoxy, alkenyl, alkyloxy, hydroxyalkyloxy, alkyloxyalkyloxy, alkyloxycarbonyl, aminoalkyloxy, mono- or di- alkylaminoalkyloxy, Ar2, Ar2-alkyl, Ar2-oxy or Ar2-alkyloxy or on adjacent positions R2 and R1 together may be -O-CH2-O-, -O-CH2-CH2-O-, -O-CH=CH-, -O-CH2-CH2-, -O-CH2- CH2- CH2- or -CH=CH-CH=CH; R3 and R4 are independently H, halo, CN, alkyl, alkyloxy, Ar3-oxy, alkylthio, dialkylamino, trihalomethyl, trihalomethoxy or on adjacent positions R2 and R1 together may be -O-CH2-O-, -O-CH2-CH2-O- or -CH=CH-CH=CH; R5 is an optionally substituted 1- or 2- imidazolyl; R6 is H, OH, alkyl, CN, haloalkyl, hydroxyalkyl, cyanoalkyl, aminoalkyl, alkyloxyalkyl, alkylthioalkyl, aminocarbonylalkyl, alkyloxycarbonylalkyl, alkylcarbonylalkyl, alkyloxycarbonyl, mono- or di- alkylaminoalkyl, Ar5, Ar5-alkyloxyalkyl, OR7, SR7 or NR8R9; Ar1 to Ar3 and Ar5 are independently optionally substituted phenyl and the rest of the variables are as defined in the specification. A pharmaceutical composition thereof is useful for inhibiting tumour growth and proliferative diseases. A compound of formula VI wherein X, R1, R2 and A are as defined above provided that if X is oxygen and A is -CH2-CH2- then R1 and R2 are not both H is disclosed. Also disclosed is a compound of formula II wherein X, Z, and R1 to R4 are as defined above. |
